XXVI EFMC International Symposium on Medicinal Chemistry 2021


Sunday, August 29, 2021 - Thursday, September 2, 2021


Attendee at XXVI EFMC International Symposium on Medicinal Chemistry 2021

EFMC-ISMC 2021 will feature major therapeutic drug discovery advancements including bacterial and viral infections, diseases of the brain, heart, and respiratory system, fibrotic diseases, and cancer.

EFMC-ISMC 2021 will also feature cutting-edge technologies such as:

  • Artificial intelligence in drug discovery and chemical synthesis
  • The role carbohydrates play in disease pathology and carbohydrate-based drug discovery
  • The exploitation of RNA as a drug target
  • Small molecule-induced stem cell differentiation
  • The impact of cryo-EM on drug discovery and design

The series will highlight the interface between chemical biology and drug discovery, including the use of chemical probes for target discovery, molecular imaging, and photochemical approaches. In response to frequent requests by attendees of previous conferences, two sessions will focus on advances in synthetic methodology for drug discovery. Finally, there will be a large emphasis on first time disclosures and recent highlights in medicinal chemistry.

Don't miss our 45-minute workshop featuring Elisa Pasqua, Group Leader at Charles River as she discusses Developing Inhaled Drugs for Respiratory Diseases: a Medicinal Chemistry Perspective.

Workshop Description:

Lung diseases continue to have a devastating impact on human health. Given the prevalence of the diseases, there is still a critical unmet need for the advancement of inhaled delivery products. There are many advantages to delivering a therapeutic directly to the lungs, however, designing a drug for inhaled delivery poses a great challenge. Watch this presentation to learn more about designing effective drugs for inhaled delivery.

Are you interested in meeting with one of our expert scientists? Complete the form to the right, and we’ll be in touch with scheduling options.